Abstract
Phytoestrogens are naturally occurring constituents of plants present in the significant proportion of our diet. They have been extensively studied due to their potential as pharmacological targets and nutraceutical benefits. The potential pharmacological applications of these molecules include cardioprotection, antimicrobial, anticancer, anti-obesity, antiosteoporosis, antidiabetic, and neuroprotection. Phytoestrogens are polyphenolic nonsteroidal compounds of plant origin with estrogen-like biological activity. They mimic estradiol-like effects in several tissue/tissues of the mammalian body. The health benefits accredited to them are due to their ability to mimic estrogenic actions. In this chapter, we aim to provide comprehensive coverage of the pharmacological aspects of the most pronounced phytoestrogens of our daily life. We will discuss different classes of phytoestrogens under the subcategory of flavonoids and non-flavonoids. Numerous plant-derived compounds like genistein, daidzein, 8-prenylnaringenin, equol, quercetin, coumestrol, isoliquiritigenin, and resveratrol belonging to different classes of phytoestrogens will be discussed with their therapeutic values and clinical applications in a broad range of health-related problems and disorders.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Rietjens IM, Sotoca AM, Vervoort J, Louisse J (2013) Mechanisms underlying the dualistic mode of action of major soy isoflavones in relation to cell proliferation and cancer risks. Mol Nutr Food Res 57:100–113
Knight DC, Eden JA (1996) A review of the clinical effects of phytoestrogens. Obstet Gynecol 87:897–904
Yildiz F (2005) Phytoestrogens in Functional Foods. Taylor & Francis Ltd, Boca Raton, pp 3–5:210–211
Paterni I., Granchi C., Katzenellenbogen J.A, Minutolo F. (2014) Estrogen receptors alpha (ERα) and beta (ERβ): subtype-selective ligands and clinical potential. Steroids 90 13–29 S0039-128X(14: 00151–00152
Böttner M, Thelen P, Jarry H (2013) Estrogen receptor beta: Tissue distribution and the still largely enigmatic physiological function. J Steroid Biochem Mol Biol 139:245–251 pii: S0960-0760(13)00052-6
Anderson JJB, Anthony M, Messina M, Garner SC (1999) Effects of phyto-oestrogens on tissues. Nutr Res Rev 12:75–116
Messina MJ, Loprinzi CL (2001) Soy for breast cancer survivors: a critical review of the literature. J Nutr 131:3095S–3108S
Adlercreutz H (1998b) Evolution, nutrition, intestinal microflora, and prevention of cancer: a hypothesis. Proc Soc Exp Biol Med 217:241–246
Kurzer MS, Xu X (1997) Dietary phytoestrogens. Annu Rev Nutr 17:353–381
Carlson S, Peng N, Prasain JK, Wyss JM (2008) Effects of botanical dietary supplements on cardiovascular, cognitive, and metabolic function in males and females. Gen Med 5:S76–S90
Martin JHJ, Crotty S, Warren P, Nelson PN (2007) Does an apple a day keep the doctor away because a phytoestrogen a day keeps the virus at bay? A review of antiviral properties of phytoestrogen. Phytochemistry 68:266–274
Januario AH, Lourenco MV, Domezio LA, Pietro R, Castilho MS, Tomazela DM, da Silva M, Vieira PC, Fernandes JB, Franca SD (2005) Isolation and structure determination of bioactive isoflavones from callus culture of Dipteryx odorata. Chem Pharm Bull 53:740
Hu J-Y, Aizawa T (2003) Quantitative structure–activity relationships for estrogen receptor binding affinity of phenolic chemicals. Water Res 37:1213–1222
Brzozowski AM, Pike ACW, Dauter Z et al (1997) Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 389:753–758
Vaya J, Tamir S (2004) The relation between the chemical structure of flavonoids and their estrogen-like activities. Curr Med Chem 11:1333–1343
Cassidy A, Bingham S, Setchell K (1995) Biological effects of isoflavones in young women: importance of the chemical composition of soyabean products. Br J Nutr 74:587–601
Fatima A, Singh R (2016) The chemistry and pharmacology of genistein. Nat Prod J 6:3–12
Makiewicz L, Garey J, Adlercreutz H, Gurpide E (1993) In vitro bioassays of non-steroidal phytoestrogens. J Steroid Biochem Mol Biol 45:399–405
Shutt DA, Cox RI (1972) Steroid and phyto-estrogen binding to sheep Uterine receptors in vitro. J Endocrinol 52:291–310
Kuiper GGJM, Lemmen JG, Carlsson B et al (1998) Interaction of estrogenic chemicals and phytoestrogens with estrogen. Endocrinology 139:4252–4263
Wang TT, Sathymoorthy N, Phang JM (1996) Molecular effects genistein on estrogen receptor mediated pathways. Carcinogenesis 17:271–275
Agarwal R (2000) Cell signaling and regulators of cell cycle as molecular targets for prostate cancer prevention by dietary agents. Biochem Pharmacol 60:1051–1059
Lakshman M, Li X, Vijayalakshmi A, Joshua C, Takimoto Chris H, Irene H, Pelling Jill C, Bergan Raymond C (2008) Dietary Genistein inhibits metastasis of human prostate cancer in mice. Cancer Res 68:20–24
Pavese JM, Krishn SN, Bergan RC (2014) Genistein inhibits human prostate cancer cell detachment, invasion, and metastasis. Am J Clin Nutr 100:431S–436S
Caruso MG, Notarnicola M, Cavallini A, Guerra V, Misciagna G, Di Leo A (1993) Demonstration of low density lipoprotein receptor in human colonic carcinoma and in surrounding mucosa by immunoenzymatic assay. Ital J Gastroenterol 25:361
Qi W, Weber CR, Wasland K, Savkovic SD (2011) Genistein inhibits proliferation of colon cancer cells by attenuating a negative effect of epidermal growth factor on tumor suppressor FOXO3 activity. BMC Cancer 11:219
Kaushik S, Shyam H, Sharma R, Balapure AK (2016) Genistein synergizes centchroman action in human breast cancer cells. Indian J Pharm 48:637–642
Sarkar FH, Li Y (2006) Using chemopreventive agents to enhance the efficacy of cancer therapy. Cancer Res 66:3347–3350
Mohammad RM, Banerjee S, Li Y, Aboukameel A, Kucuk O, Sarkar FH (2006) Cisplatin-induced antitumor activity is potentiated by the soy isoflavone genistein in BxPC-3 pancreatic tumor xenografts. Cancer 106:1260–1268
Hwang JT, Park IJ, Shin JI, Lee YK, Lee SK, Baik HW, Ha J, Park OJ (2005) Genistein, EGCG, and capsaicin inhibit adipocyte differentiation process via activating AMP-activated protein kinase. Biochem Biophys Res Commun 338:694–699
Aditya NP, Shim M, Yang H, Lee YJ, Ko S (2014) Antiangiogenic effect of combined treatment with curcumin and genistein on human prostate cancer cell line. J Funct Foods 8:204–213
Chang KL, Cheng HL, Huang LW, Hsieh BS, Hu YC, Chi TT, Shyu HW, Su SJ (2009) Combined effects of terazosin and genistein on a metastatic, hormone-independent human prostate cancer cell line. Cancer Lett 276:14–20
Park HJ, Della-Fera MA, Hausman DB, Rayalam S, Ambatia S, Baile CA (2009) Genistein inhibits differentiation of primary human adipocytes. J Nutr Biochem 20:140–148
Aguero MF, Fachinetti MM, sheleg Z, Senderowicz AM (2005) phenoxodiol: a novel isoflavone, induces G1 arrest by specific loss in cyclin dependent kinase 2 activity by p- 53 independent induction of p21WAF1/CIP1. Cancer Res 65:3364–3373
Choueiri TK, Mekhail T, Hutson TE, Ganapathi R, Kelly GE, Bukowsky RM (2006) Phase I trial of phenoxodiol delivered by continuous intravenous infusion in patients with solid cancer. Ann Oncol 17:860–865
Rickard DJ, Monroe DG, Ruesink TJ, Khosla S, Riggs BL, Spelsberg TC (2003) Phytoestrogen genistein acts as an estrogen agonist on human osteoblastic cells through estrogen receptors alpha and beta. J Cell Biochem 89:633–646
Yamagishi T, Otsuka E, Hagiwara H (2001) Reciprocal control of expression of mRNAs for osteoclast differentiation factor and OPG in osteogenic stromal cells by genistein: evidence for the involvement of topoisomerase II in osteoclas- togenesis. Endocrinology 142:3632–3637
Atteritano M, Pernice F, Mazzaferro S, Mantuano S, Frisina A, D'Anna R, Cannata ML, Bitto A, Squadrito F, Frisina N, Buemi M (2008) Effects of phytoestrogen genistein on cytogenetic biomarkers in postmenopausal women: 1 year randomized, placebo-controlled study. Eur J Pharmacol 589:22–26
Sehmisch S, Uffenorde J, Maehlmeyer S, Tezval M, Jarry H, Stuermer KM, Stuermer EK (2010) Evaluation of bone quality and quantity in osteoporotic mice–The effects of genistein and equol. Phytomedicine 17:424–430
Choi EJ, Kim G (2008) Daidzein causes cell cycle arrest at the G1 and G2/M phases in human breast cancer MCF-7 and MDA-MB-453 cells. Phytomedicine 15:683–690
Bhathena SJ, Velasquez MT (2002) Beneficial role of dietary phytoestrogens in obesity and diabetes. Am J Clin Nutr 76:1191–1201
Hamideh S, Marcus BM, Antonio A, Marcelo HL (2011) The antioxidant effect of genistein on the in vitro metal -mediated formation of free radicals. Clin Biochem 44:S226–S226
Palanisamy N, Kannappan S, Anuradha CV (2011) Genistein modulates NF-kB-associated renal inflammation, fibrosis and podocyte abnormalities in fructose-fed rats. Eur J Pharmacol 667:355–364
Gelinas S, Martinoli MG (2002) Neuroprotective effect of estradiol and phytoestrogens on MPP+-induced cytotoxicity in neuronal PC12 cells. J Neurosci Res 70:90–96
Liu LX, Chen W, Xie J, Wong M (2008) Neuroprotective effects of genistein on dopaminergic neurons in the mice model of Parkinson’s disease. Neurosci Res 60:156–161
Gao Q, Xie J, Wong M, Chen W (2012) IGF-I receptor signaling pathway is involved in the neuroprotective effect of genistein in the neuroblastoma SK-N-SH cells. Eur J Pharmacol 677:39–46
Jakob-Roetne R, Jacobsen H (2009) Alzheimer’s disease: from pathology to therapeutic approaches. Angew Chem Int Ed Eng 48:3030–3059
Bagheri M, Roghanid M, Joghataeib M, Mohsenia S (2012) Genistein inhibits aggregation of exogenous amyloid-beta1-40 and alleviates astrogliosis is in the hippocampus of rats. Brain Res 1429:145–154
Alonso A, Gonzalez-Pardo H, Garrido P et al (2010) Acute effects of 17 beta-estradiol and genistein on insulin sensitivity and spatial memory in aged ovariectomized female rats. Age (Dordr) 32(4):421–434
Bagheri M, Joghataei M-T, Mohsen S, Roghani M (2011) Genistein ameliorates learning and memory deficits in amyloid β(1-40) rat model of Alzheimer’s disease. Neurobiol Learn Mem 95:270–276
ClinicalTrials.gov identifier: NCT01982578l Genistein as a Possible Treatment for Alzheimer's Disease. (GENISTEÍNA_2)l juy 2015).
Zhang X, Wang J, Hong C, Luon W, Wang C (2015) Design, synthesis and evaluation of genistein-polyamine conjugates as multi-functional anti-Alzheimer agents. Acta Pharm Sin B 5:67–73
Sathyamoorthy N, Wang TT (1997) Differential effects of dietary phyto-oestrogens daidzein and equol on human breast cancer MCF-7 cells. Eur J Cancer 33:2384–2389
Guo JM, Kang GZ, Xiao BX, Liu DH, Zhang S (2004) Effect of daidzein on cell growth, cell cycle, and telomerase activity of human cervical cancer in vitro. Int J Gynecol Cancer 14:882–888
Lee JS, Son KH, Sung MK, Kim YK, Yu R, Kim JS (2003) Anticarcinogenic properties of a daidzein-rich fraction isolated from soybean. J Med Food 6:175–181
Rabiau N, Kossaï M, Braud M, Chalabi N, Satih S, Bignon YJ, Bernard-Gallon DJ (2010) Genistein and daidzein act on a panel of genes implicated in cell cycle and angiogenesis by polymerase chain reaction arrays in human prostate cancer cell lines. Cancer Epidemiol 34:200–206
Somjen D, Katzburg S, Nevo N, Gayera B, Hodged RP, Reneveyd MD, Kalchenko V, Meshorere A, Sternc N, Kohena F (2008) A daidzein–daunomycin conjugate improves the therapeutic response in an animal model of ovarian carcinoma. J Steroid Biochem Mol Biol 110:144–149
Yamaguchi M, Sugimoto E (2000) Stimulatory effect of genistein and daidzein on protein synthesis in osteoblastic MC3T3-E1 cells: activation of aminoacyl-tRNA synthetase. Mol Cell Biochem 214:97
Yadav DK, Gautam AK, Kureel J, Srivastava K, Sahai M, Singh D, Chattopadhyay N, Maurya R (2011) Synthetic analogs of daidzein, having more potent osteoblast stimulating effect. Bioorg Med Chem Lett 21:677–681
Pagano L, Teofili L, Mele L, Piantelli M, Ranelletti FO et al (1999) Oral ipriflavone (7-isopropoxy-isoflavone) treatment for elderly patients with resistant acute leukemias. Ann Oncol 10:124–125
Petilli M, Fiorolli G, Benvenuti S, Frediani U, Gorif BMLIBI, estrogen r (1995) Calcif Tissue Int 56:160–165
Kampkötter A, Chovolou A, Kulawik A, Röhrdanz E, Weber N, Proksch P, Wätjen W (2008) Isoflavone daidzein possesses no antioxidant activities in cell-free assays but induces the antioxidant enzyme catalase. Nutr Res 28:620–628
Gredel S, Grad C, Rechkemmer G, Watzl B (2008) Phytoestrogens and phytoestrogen metabolites differentially modulate immune parameters in human leukocytes. Food Chem Toxicol 46:3691–3696
Yum MK, Jung MY, Cho D, Kim TS (2011) Suppression of dendritic cells’ maturation and functions by daidzein, a phytoestrogen. Toxicol Appl Pharmacol 257:174–181
Xu SZ, Zhong W, Ghavideldarestani M, Saurabh S, Lindow SW, Atkin SL (2009) Multiple mechanisms of soy isoflavones against oxidative stress-induced endothelium injury. Free Radic Biol Med 47:167–175
Hsieh H, Wua W, Hu M (2009) Soy isoflavones attenuate oxidative stress and improve parameters related to aging and Alzheimer’s disease in C57BL/6J mice treated with D-galactose. Food Chem Toxicol 47:625–632
Borradaile NM, Dedreu LE, Wilcox LJ (2002) Soya phytoestrogens, genistein and daidzein, decrease apolipoprotein B secretion from HepG2 cells through multiple mechanisms. Biochem J 366:531–539
He Y, Niu W, Xia C, Cao B (2016) Daidzein reduces the proliferation and adiposeness of 3T3-L1 preadipocytes via regulating adipogenic gene expression. J Funct Foods 22:446–453
Song TT, Hendrich S, Murphy PA (1999) Estrogenic activity of glycitein, a soy isoflavone. J Agric Food Chem 47:1607–1610
Gutierrez-Zepeda A, Santell R, Wu Z, Brown M, Wu Y, Khan I, Link CD, Zhao B, Luo Y (2005) Soy isoflavone glycitein protects against beta amyloid-induced toxicity and oxidative stress in transgenic Caenorhabditis elegans. BMC Neurosci 6:54
Chen ZY, Ma KY, Liang Y, Peng C, Zuo Y (2011) Role and classification of cholesterol-lowing functional foods. J Funct Foods 3:61–69
Lin CC, Chen TS, Lin YM, Yeh YL, Li YH, Kuo WW, Tsai FJ, Tsai CH, Yen SK, Huang CY (2013) The p38 and NFjB signaling protein activation involved in glycitein protective effects on isoproterenol-treated H9c2 cardiomyoblast cells. J Funct Foods 5:460–465
Mu H, Bai YH, Wang ST, Zhu ZM, Zhang YW (2008) Research on antioxidant effects and estrogenic effect of formononetin from Trifolium pratense (red clover). Phytomedicine 16:314–319
Wu J, Li Q, Wu M, Guo D, Chen H, Chen S, Seto S, Alice LSA, Poon CCW, Leung GPH, Lee SMY, Kwan Y, Chan S (2010) Formononetin, an isoflavone, relaxes rat isolated aorta through endothelium-dependent and endothelium-independent pathways. J Nutr Biochem 21:613–620
Kawai M, Hirano T, Higa S, Arimitsu J, Maruta M, Kuwahara Y, Ohkawara T, Hagihara K, Yamadori T, Shima Y, Ogata A, Kawase I, Tanaka T (2007) Flavonoids and related compounds as anti-allergic substances. Allergol Int 56:113–123
Theoharides TC, Alexandrakis M, Kempuraj D, Lytinas M (2001) Anti-inflammatory actions of flavonoids and structural requirements for new design. Int J Immunopathol Pharmacol 14:119–127
Arao T, Udayama M, Kinjo J, Nohara T, Funakoshi T, Kojima S (1997) Preventive effects of saponins from Puerariae radix (the root of Pueraria lobata Ohwi) on in vitro immunological injury of rat primary hepatocyte cultures. Biol Pharm Bull 20:988–991
Wolfe K, Wu X, Liu RH (2003) Antioxidant activity of apple peels. J Agric Food Chem 51:609–614
Joshi KS, Rathos MJ, Joshi RD, Sivakumar M, Mascarenhas M, Kamble S, Lal B, Sharma S (2007) In vitro antitumor properties of a novel cyclin-dependent kinase inhibitor. P276-00. Mol Cancer Ther 6:918–925
Formica JV, Regelson W (1995) Review of the biology of quercetin and related bioflavonoids. Food Chem Toxicol 33:1061–1080
Middleton E Jr, Kandaswami C, Theoharides TC (2000) The effects of plant flavonoids on mammalian cells: implications for inflammation. Heart disease and cancer. Pharmacol Rev 52:673–751
Wang L, Tu YC, Lian TW, Hung JT, Yen JH, Wu MJ (2006) Distinctive antioxidant and antiinflammatory effects of flavonols. J Agric Food Chem 54:9798–9804
Khan TH, Jahangir T, Prasad L et al (2006) Inhibitory effect of apigenin on benzo(a)pyrene mediated genotoxicity in Swiss albino mice. J Pharm Pharmacol 58:1650–1655
Siddique YH, Afzal M (2009) Antigenotoxic effect of apigenin against mitomycin C induced genotoxic damage in mice bone marrow cells. Food Chem Toxicol 47:536–539
King JC, Lu Q, Li G, Moro A, Takahashi H, Chen M, Go VLW, Reber HA, Eibl G, Hines OJ (2012) Evidence for activation of mutated p53 by apigenin in human pancreatic cancer. Biochim Biophys Acta 1823:593–604
Strouch MJ, Milam BM, Melstrom LG, McGill JJ, Salabat MR, Ujiki MB, Ding XZ, Bentrem DJ (2009) The flavonoid apigenin potentiates the growth inhibitory effects of gemcitabine and abrogates gemcitabine resistance in human pancreatic cancer cells. Pancreas 38:409–415
Han JY, Ahn SY, Kim CS, Yoo SK, Kim SK et al (2012) Protection of apigenin against kainate-induced excitotoxicity by anti-oxidative effects. Biol Pharm Bull 35:1440–1446
Jagan K, Priya CS, Kalpana K, Vidhya R, Anuradha CV (2017) Apigenin attenuates hippocampal oxidative events, inflammation and pathological alterations in rats fed high fat, fructose diet. Biomed Pharmacother 89:323–331
Erdogan S, Turkekul K, Serttas R, Erdogan Z (2017) The natural flavonoid apigenin sensitizes human CD44+ prostate cancer stem cells to cisplatin therapy. Biomed Pharmacother 88:210–217
Paoletti T, Fallarini S, Gugliesi F, Minassi A, Appendino G, Lombardi G (2009) Anti-inflammatory and vascular protective properties of 8-prenylapigenin. Eur J Pharmacol 620:120–130
Milligan SR, Kalita JC, Heyerick A, Rong H, Cooman L, Keukeleire D (1999) Identification of a potent phytoestrogen in hops (Humulus lupulus L.) and beer. J Clin Endocrinol Metab 83:2249–2252
Milligan SR, Kalita JC, Pocock V, Van De Kauter V, Stevens JF, Deinzer ML, Rong H, De Keukeleire D (2000) The endocrine activities of 8-prenylnaringenin and related hop (Humulus lupulus L.) flavonoids. J Clin Endocrinol Metab 85:4912–4915
Matsumura A, Ghosh A, Pope GS, Darbre PD (2005) Comparative study of oestrogenic properties of eight phytoestrogens in MCF7 human breast cancer cells. J Steroid Biochem Mol Biol 94:431–443
Brunelli E, Minassi A, Appendino G, Moro L (2007) 8-Prenylnaringenin, inhibits estrogen receptor-a mediated cell growth and induces apoptosis in MCF-7 breast cancer cells. J Steroid Biochem Mol Biol 107:140–148
Brunelli E, Pinton G, Chianale F, Graziani A, Appendino G, Moro L (2009) 8-Prenylnaringenin inhibits epidermal growth factor-induced MCF-7 breast cancer cell proliferation by targeting phosphatidylinositol-3-OH kinase activity. J Steroid Biochem Mol Biol 113:163–170
Helle J, Kräker K, Bader MI, Keiler AM, Zierau O, Vollmer G, Welsh JE, Kretzschmar G (2014) Assessment of the proliferative capacity of the flavanones 8-prenylnaringenin, 6-(1.1-dimethylallyl)naringenin and naringenin in MCF-7 cells and the rat mammary gland. Mol Cell Endocrinol 392:125–135
Vito CD, Bertoni A, Nalin M, Sampietro S, Zanfa M, Sinigaglia F (2012) The phytoestrogen 8-prenylnaringenin inhibits agonist-dependent activation of human platelets. Biochimica et Biophysica Acta (BBA) 1820:1724–1733
Wang J, Fang F, Huang Z, Wang Y, Wong C (2009) Kaempferol is an estrogen-related receptor a and c inverse agonist. FEBS Lett 583:643–647
Strauss L, Santti R, Saarinen N, Streng T, Joshi S, Mäkelä S (1998) Dietary phytoestrogens and their role in hormonally dependent disease. Toxicol Lett 102–103:349–354
Sahu SC, Gray GC (1994) Kaempferol-induced nuclear DNA damage and lipid peroxidation. Cancer Lett 85:159–164
Zhang Y, Chen AY, Li M, Chen C, Yao Q (2008) Ginkgo biloba extract kaempferol inhibits cell proliferation and induces apoptosis in pancreatic cancer cells. J Surg Res 148:17–23
Kim S-H, Choi K-C (2013) Anti-cancer effect and underlying mechanism(s) of kaempferol, a phytoestrogen, on the regulation of apoptosis in diverse cancer cell models. Toxicol Res 29:229–234
Kashafi E, Moradzadeh M, Mohamadkhani A, Erfaniand S (2017) Kaempferol increases apoptosis in human cervical cancer HeLa cells via PI3K/AKT and telomerase pathways. Biomed Pharmacother 89:573–577
Zhang R, Ai X, Duan Y, Xue M, He W, Wang C, Xu T, Xu M, Liu B, Li C, Wang Z, Zhang R, Wang G, Tian S, Liu H (2017) Kaempferol ameliorates H9N2 swine influenza virus-induced acute lung injury by inactivation of TLR4/MyD88-mediated NF-kB and MAPK signaling pathways. Biomed Pharmacother 89:660–672
Wu J, Du J, Xu C, Le J, Liu B, Xu Y et al (2010) In vivo and in vitro anti-inflammatory effects of a novel derivative of icariin. Immunopharmacol Immunotoxicol 33:49–54
Meng FH, Li YB, Xiong ZL, Jiang ZM, Li FM (2005) Osteoblastic proliferative activity of Epimedium brevicornum Maxim. Phytomedicine 12:189–193
Sakai S, Tamura M, Mishima H, Kojima H, Uemura T (2008) Bone regeneration induced by adenoviral vectors carrying til-1/Cbfa1 genes implanted with biodegradable porous materials in animal models of osteonecrosis of the femoral head. J Tissue Eng Regen Med 2:164–167
Hsieh T, Sheu S, Sun J, Chen M, Liu M (2010) Icariin isolated from Epimedium pubescens regulates osteoblasts anabolism through BMP-2, SMAD4, and Cbfa1 expression. Phytomedicine 17:414–423
Qian ZQ, Wang YW, Li YL, Li YQ, Zhu L, Yanga DL (2017) Icariin prevents hypertension-induced cardiomyocyte apoptosis through the mitochondrial apoptotic pathway. Biomed Pharmacother 88:823–831
Algandaby MM, Breikaa RM, Eid BG, Neamatallah TA, Abdel-Naim AB, Ashour OM (2017) Icariin protects against Thioacetamide-induced liver fibrosis in rats: implication of anti-angiogenic and anti-autophagic properties. Pharmacol Rep. https://doi.org/10.1016/j.pharep.2017.02.016
Xiong D, Deng Y, Huang B, Yin C, Liu B, Shi J et al (2016) Icariin attenuates cerebral ischemia-reperfusion injury through inhibition of inflammatory response mediated by NF-κB, PPARα and PPARγ in rats. Int Immunopharmacol 30:157–162
Wu JW, Lin LC, Tsai TH (2009) Drug–drug interactions of silymarin on the perspective of pharmacokinetics. J Ethnopharmacol 121:185–193
Wellington K, Jarvis B (2001) Silymarin: a review of its clinical properties in the management of hepatic disorders. BioDrugs 15:465–489
Sonnenbichler J, Zetl I, Cody V, Middleton E, Karbone JB, Berck A (eds) (1988) Specific binding of a flavonolignane derivative to an estradiol receptor. Prog Clin Biol Res 280:369–374
El-Shitany NA, Hegazy S, El-desoky K (2010) Evidences for antiosteoporotic and selective estrogen receptor modulator activity of silymarin compared with ethinylestradiol in ovariectomized rats. Phytomedicine 17:116–125
Gharagozloo M, Velardi E, Bruscoli E, Agostini M, Di Sante M, Donato V, Amirghofran Z, Riccard C (2010) Silymarin suppress CD4+ T cell activation and proliferation: effects on NF-κB activity and IL-2 production. Pharmacol Res 61:405–409
Wu T, Liu W, Guo W, Zhu X (2016) Silymarin suppressed lung cancer growth in mice via inhibiting myeloid-derived suppressor cells. Biomed Pharmacother 81:460–467
Song JH, Choi HJ (2011) Silymarin efficacy against influenza A virus replication. Phytomedicine 18:832–835
Srivastava S, Sammi SR, Laxman TS, Pant A, Nagar A, Trivedi S, Bhatta RS, Tandon S, Pandey R (2017) Silymarin promotes longevity and alleviates Parkinson’s associated pathologies in Caenorhabditis elegans. J Funct Foods 31:32–43
Yun DG, Lee DG (2017) Silymarin exerts antifungal effects via membrane-targeted mode of action by increasing permeability and inducing oxidative stress. Biochim Biophys Acta 1859:467–474
Kimata M, Inagaki N, Nagai H (2000) Effects of luteolin and other flavonoids on IgE-mediated allergic reactions. Planta Med 66:25–29
Hong T, Jin GB, Cho S, Cyong JC (2002) Evaluation of the anti-inflammatory effect of baicalein on dextran sulfate sodium-induced colitis in mice. Planta Med 68:268–271
Piao YS, Du YC, Oshima H, Jin JC, Nomura M, Yoshimoto T, Oshima M (2008) Platelet-type 12-lipoxygenase accelerates tumor promotion of mouse epidermal cells through enhancement of cloning efficiency. Carcinogenesis 29:440–447
Kuntz S, Wenzel U, Daniel H (1999) Comparative analysis of the effects of flavonoids on proliferation, cytotoxicity, and apoptosis in human colon cancer cell lines. Eur J Nutr 38:133–142
Tong WG, Ding XZ, Adrian TE (2002a) The mechanisms of lipoxygenase inhibitor-induced apoptosis in human breast cancer cells. Biochem Biophys Res Commun 296:942–948
Tong WG, Ding XZ, Witt RC, Adrian TE (2002b) Lipoxygenase inhibitors attenuate growth of human pancreatic cancer xenografts and induce apoptosis through the mitochondrial pathway. Mol Cancer Ther 1:929–935
Chung H, Choi HS, Seo EK, Kang DK, Oh ES (2015) Baicalin and baicalein inhibit transforming growth factor-b1-mediated epithelial-mesenchymal transition in human breast epithelial cells. Biochem Biophys Res Commun 458:707–713
Chen C, Huang T, Wong C, Hong C, Tsai Y, Liang C, Lu F, Chang W (2009) Synergistic anti-cancer effect of baicalein and silymarin on human hepatoma HepG2 Cells. Food Chem Toxicol 47:638–644
Zhu M, Rajamani S, Kaylor J, Han S, Zhou F, Fink AL (2004) The flavonoid Baicalein inhibits fibrillation of Synuclein and disaggregates existing fibrils. J Biol Chem 279:26846–26857
Kang TH, Hong BN, Park C, Kim SY, Park R (2010) Effect of baicalein from Scutellaria baicalensis on prevention of noise-induced hearing loss. Neurosci Lett 469:298–302
Setchell KD, Brown NM, Lydeking-Olsen E (2002) The clinical importance of the metabolite equol—a clue to the effectiveness of soy and its isoflavones. J Nutr 132:3577
Muthyala RS, Ju YH, Sheng S, Williams LD, Doerge DR, Katzenellenbogen BS, Helferich WG, Katzenellenbogen JA (2004) Equol, a natural estrogenic metabolite from soy isoflavones: convenient preparation and resolution of R- and S-equols and their differing binding and biological activity through estrogen receptors alpha and beta. Bioorg. Med Chem 12:1559–1567
Choi EJ, Ahn WS, Bae SM (2009) Equol induces apoptosis through cytochrome c-mediated caspases cascade in human breast cancer MDA-MB-453 cells. Chem Biol Interact 177:7–11
Jackman A, Woodman OL, Chrissobolis S, Sobey CG (2007) Vasorelaxant and antioxidant activity of the isoflavone metabolite equol in carotid and cerebral arteries. Brain Res 1141:99–107
Chung J, Kim SY, Jo HH, Hwang SJ, Chae B, Kwon DJ, Lew YO, Lim Y, Kim JH, Kim EJ, Kim J, Kim M (2008) Antioxidant effects of equol on bovine aortic endothelial cells. Biochem Biophys Res Commun 375:420–424
Setchell KD, Lydeking-Olsen E (2003) Dietary phytoestrogens and their effect on bone: evidence from in vitro and in vivo, human observational, and dietary intervention studies. Am J Clin Nutr 78:593S–609S
Lampe JW (2009) Is equol the key to the efficacy of soy foods? Am J Clin Nutr 89:1664S–1667S
Davinelli S, Scapagnini G, Marzatico F, Nobile V, Ferrara N, Corbi G (2017) Influence of equol and resveratrol supplementation on health-related quality of life in menopausal women: a randomized, placebo-controlled study. Maturitas 96:77–83
Knekt P, Jarvinen R, Seppanen R, Hellovaara M, Teppo L, Pukkala E, Aroma A (1997) Dietary flavonoids and the risk of lung cancer and other malignant neoplasms. Am J Epidemiol 146:223–230
Geleijnse JM, Launer LJ, Van der Kuip DA, Hofman A, Witteman JC (2002) Inverse association of tea and flavonoid intakes with incident myocardial infarction: the Rotterdam Study. Am J Clin Nutr 75:880–886
Rice-Evans CA, Miller NJ, Paganga G (1996) Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic Biol Med 20:933–956
Agullo G, Gamet-Payrastre L, Fernandez Y, Anciaux N, Demigne C, Remesy C (1996) Comparative effects of flavonoids on the growth, viability and metabolism of a colonic adenocarcinoma cell line (HT29 cells). Cancer Lett 105:61–70
Russo M, Palumbo R, Tedesco I, Mazzarella G, Russo P, Iacomino G, Russo GL (1999) Quercetin and anti-CD95(Fas/ Apo1) enhance apoptosis in HPB-ALL cell line. FEBS Lett 462:322–328
Sotocaa AM, Ratman D, Saag PV, Ström A, Gustafsson JA, Vervoort J, Rietjens IMCM, Murk AJ (2008) Phytoestrogen-mediated inhibition of proliferation of the human T47D breast cancer cells depends on the ER_/ER_ ratio. J Steroid Biochem Mol Biol 112:171–178
Bernad FX, Sable S, Cameron B (1997) glycosylated flavones as selective inhibitors of topoisomerases IV. Antimicrob Agents Chemother 41:992–998
Kim MK, Choo H, Chong Y (2014) Water-soluble and cleavable Quercetin−amino acid conjugates as safe modulators for P-glycoprotein-based multidrug resistance. J Med Chem 57:7216−7233
Haleagrahara N, Miranda-Hernandez S, Alim MA, Hayesa L, Bird G, Ketheesan N (2017) Therapeutic effect of quercetin in collagen-induced arthritis. Biomed Pharmacother 90:38–46
Whitten PL, Naftolin F (1998) Reproductive actions of phytoestrogens. Bailliere Clin Endocrinol Metab 12:667–690
Saarinen NM, Penttinen PE, Smeds AI, Hurmerinta TT, Makela SI (2005) Structural determinants of plant lignans for growth of mammary tumors and hormonal responses in vivo. J Steroid Biochem Mol Biol 93:209–219
Zafar A, Singh S, Naseem I (2016) Cytotoxic activity of soy phytoestrogen coumestrol against human breast cancer MCF-7 cells: insights into the molecular mechanism. Food Chem Toxicol. https://doi.org/10.1016/j.fct.2016.11.034
Lim W, Jeong M, Bazer FW, Song G (2017) Coumestrol inhibits proliferation and migration of prostate cancer cells by regulating AKT, ERK1/2, and JNK MAPK cell signaling cascades. J Cell Physiol 232(4):862–871
Tsutsumi N (1995) Effect of coumestrol on bone metabolism in organ culture. Biol Pharm Bull 18:1012–1015
Wang H, Li H, Moore LB, Johnson MDL, Maglich JM, Goodwin B, Ittoop ORR, Wisely B, Creech K, Parks DJ, Collins JL, Willson TM, Kalpana GV, Venkatesh M, Xie W, Cho SY, Roboz J, Redinbo M, Moore JT, Mani S (2008) The phytoestrogen coumestrol is a naturally occurring antagonist of the human Pregnane X receptor. Mol Endocrinol 22:838–857
Zhai Y, Li Y, Wang Y, Cui J, Feng K, Kong X, Chen L (2017) Psoralidin, a prenylated coumestan, as a novel anti-osteoporosis candidate to enhance bone formation of osteoblasts and decrease bone resorption of osteoclasts. Eur J Pharmacol Apr 15(801):62–71
Hong Y, Cho M, Yuan Y, Chen S (2008) Molecular basis for the interaction of four different classes of substrates and inhibitors with human aromatase. Biochem Pharmacol 75:1161–1169
Whitten PL, Patisaul HB, Younga LJ (2002) Neurobehavioral actions of coumestrol and related isoflavonoids in rodents. Neurotoxicol Teratol 24:47–54
Canal Castro C, Pagnussat AS, Orlandi L, Worm P, Moura N, Etgen AM, Alexandre Netto C (2012) Coumestrol has neuroprotective effects before and after global cerebral ischemia in female rats. Brain Res 1474:82–90
Dai Q, Franke AA, Jin F, Shu XO, Hebert JR et al (2002) Urinary excretion of phytoestrogens and risk of breast cancer among Chinese women in Shanghai. Cancer Epidemiol Biomark Prev 11:815–821
De Kleijn MJJ, Van der Schouw YT, Wilson PWF, Grobbee DE, Jacques PF (2002) Dietary intake of phytoestrogens is associated with a favorable metabolic cardiovascular risk profile in postmenopausal U.S. women: the Framingham study. J Nutr 132:276–282
Aehle E, Müller U, Eklund PC, Willför SM, Sippl W, Dräger B (2011) Lignans as food constituents with estrogen and antiestrogen activity. Phytochemistry 72:2396–2405
Adlercreutz H, Höckerstedt K, Bannwart C, Bloigu S, Hämäläinen E, Fotsis T, Ollus A (1987) Effect of dietary components, including lignans and phytoestrogens, on enterohepatic circulation and liver metabolism of estrogens and on sex hormone binding globulin (SHBG). Journal of Steroid Biochemistry 27:1135–1144
Prasad K (2000) Antioxidant activity of secoisolariciresinol diglucoside- derived metabolites secoisolariciresinol. Enterodiol, and enterolactone. Int J Angiol 9:220–225
Boccardo F, Lunardi G, Guglielmini P, Parodi M, Murialdo R, Schettini G, Rubagotti A (2004) Serum enterolactone levels and the risk of breast cancer in women with palpable cysts. Eur J Cancer 40:84–89
Mousavi Y, Adlercreutz H (1992) Enterolactone and estradiol inhibit each other’s proliferative effect on MCF-7 breast cancer cells in culture. J Steroid Biochem Mol Biol 41:615–619
Figueiredo MS, Maia LA, Guarda DS, Lisboa PC, Moura EG (2017) Flaxseed secoisolariciresinol diglucoside (SDG) during lactation improves bone metabolism in offspring at adulthood. J Funct Foods 29:161–171
Ma X, Wang R, Zhao X, Zhang C, Sun J, Li J, Zhang L, Shao T, Ruan L, Chen L, Xu Y, Pan J (2013) Antidepressant-like effect of flaxseed secoisolariciresinol diglycoside in ovariectomized mice subjected to unpredictable chronic stress. Metab Brain Dis 28:77–84
Hu P, Mei QY, Ma L, Cui WG, Zhou WH, Zhou DS, Zhao Q, Xu DY, Zhao X, Lu Q, Hu ZY (2015) Secoisolariciresinol diglycoside, a flaxseed lignan, exerts analgesic effects in a mouse model of type 1 diabetes: engagement of antioxidant mechanism. Eur J Pharmacol 767(15):183–192
Stewart JR, Christman KL, O’Brian CA (2000) Effects of resveratrol on the autophosphorylation of phorbol ester-responsive protein kinases: inhibition of protein kinase D but not protein kinase C isozyme autophosphorylation. Biochem Pharmacol 60:1355–1359
Bhat KPL, Lantvit D, Christov K, Mehta RC, Pezzuto JM (2001) Estrogenic and antiestrogenic properties of resveratrol in mammary tumour models. Cancer Res 61:7456–7463
Stojanovic S, Sprinz H, Brede O (2001) Efficiency and mechanism of the antioxidant action of trans-resveratrol and its analogues in the radical liposome oxidation. Arch Biochem Biophys 391:79–89
Fontecave M, Lepoivre M, Elleingand E, Gerez C, Guittet O (1998) Resveratrol: a remarkable inhibitor of ribonucleotide reductase. FEBS Lett 421:277–279
Locatelli GA, Savio M, Forti L, Shevelev I, Ramadan K, Stivala LA, Vannini V, Hubscher U, Spadari S, Maga G (2005) Inhibition of mammalian DNA polymerases by resveratrol: mechanism and structural determinants. Biochem J 389:259–268
Bhat KPL, Lantvit D, Christov K, Mehta RC, Pezzuto JM (2001) Estrogenic and antiestrogenic properties of resveratrol in mammary tumour models. Cancer Res 61:7456–7463
Sakamoto T, Horiguchi H, Oguma E, Kayama F (2010) Effects of diverse dietary phytoestrogens on cell growth, cell cycle and apoptosis in estrogen-receptor-positive breast cancer cells. J Nutr Biochem 21(9):856–864
Wesierska-Gadek J, Kramer MP, Maurer M (2008) Resveratrol modulates roscovitine-mediated cell cycle arrest of human MCF-7 breast cancer cells. Food Chem Toxicol 46:1327–1333
Zhu Y, Fu J, Shurlknight KL, Soroka DN, Hu Y, Chen X, Sang S (2015) Novel resveratrol-based aspirin prodrugs: synthesis, metabolism, and anticancer activity. J Med Chem 58(16):6494–6506
Du C, Dong MH, Ren YJ, Jin L, Xu C (2016) Design, synthesis and antibreast cancer MCF-7 cells biological evaluation of heterocyclic analogs of resveratrol. J Asian Nat Prod Res 3:1–13
Alamolhodaei NS, Tsatsakis AM, Ramezani M, Hayes AW, Karimi G (2017) Resveratrol as MDR reversion molecule in breast cancer: an overview. Food Chem Toxicol 103:223–232
Anekonda TS, Reddy PH (2006) Neuronal protection by sirtuins in Alzheimer’s disease. J Neurochem 96:305–313
Karlsson J, Emgard M, Brundin P, Burkitt MJ (2000) trans-resveratrol protects embryonic mesencephalic cells from tert-butyl hydroperoxide: electron paramagnetic resonance spin trapping evidence for a radical scavenging mechanism. J Neurochem 75:141–150
ClinicalTrials.gov Identifier: NCT01504854 Phase II Study to Evaluate the Impact on Biomarkers of Resveratrol Treatment in Patients With Mild to Moderate Alzheimer’s Disease April 2016
Wallerath T, Deckert G, Ternes T, Anderson H, Li H et al (2002) Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase. Circulation 106:1652–1658
Das S, Das DK (2007) Anti-inflammatory responses of resveratrol. Inflamm Allergy Drug Targets 6:168–173
Stagos D, Portesis N, Spanou C, Mossialos D, Aligiannis N, Chaita E, Panagoulis C, Reri E, Skaltsounis L, Tsatsakis AM (2012b) Correlation of total polyphenolic content with antioxidant and antibacterial activity of 24 extracts from greek domestic Lamiaceae species. Food Chem Toxicol 50:4115–4124
Mizutani K, Keda K, Kawai Y, Yamori Y (2001) Protective effect of resveratrol on oxidative damage in male and female stroke-prone spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 28:55–59
Szkudelska K, Nogowski L, Szkudelski T (2009) Resveratrol, a naturally occurring diphenolic compound, affects lipogenesis, lipolysis and the antilipolytic action of insulin in isolated rat adipocytes. J Steroid Biochem Mol Biol 113:17–24
Sanchez-Fidalgo S, Cardeno A, Villegas I, Talero E, Alarcon de la Lastra C (2010) Dietary supplementation of resveratrol attenuates chronic colonic inflammation in mice. Eur J Pharmacol 633:78–84
De Vincenzo R, Scambia G, Panici PB, Ranelletti FO, Bonanno G, Ercoli A, Delle MF, Ferrari F, Piantelli M, Mancuso S (1995) Effect of synthetic and naturally occurring chalcones on ovarian cancer cell growth: structure–activity relationships. Anticancer Drug Des 10:481–490
Tamir S, Eizemberg M, Somjen D, Izrael S, Vaya J (2001) Estrogen-like activity of glabrene and other constituents isolated from licorice root. J Steroid Biochem Mol Biol 78:291–298
Haraguchi H, Ishikawa H, Mizutani K, Tamura Y, Kinoshita T (1998) Antioxidative and superoxide scavenging activities of retrochalcones in Glycyrrhiza inflata. Bioorg Med Chem 6:339–347
Tawata M, Aida K, Noguchi T, Ozaki Y, Kume S, Sasaki H, Chin M, Onaya T (1992) Anti-platelet action of isoliquiritigenin, an aldose reductase inhibitor in licorice. Eur J Pharmacol 212:87–92
Chowdhury SA, Kishino K, Satoh R, Hashimoto K, Kikuchi H, Nishikawa H, Shirataki Y, Sakagami H (2005) Tumor-specificity and apoptosis-inducing activity of stilbenes and flavonoids. Anticancer Res 25:2055–2063
Takahashi T, Takasuka N, Iigo M, Baba M, Nishino H, Tsuda H, Okuyama T (2004) Isoliquiritigenin, a flavonoid from licorice, reduces prostaglandin E2 and nitric oxide, causes apoptosis, and suppresses aberrant crypt foci development. Cancer Sci 95:448–453
Jung JI, Chung E, Seon MR, Shin HK, Kim EJ, Lim SS, Chung WY, Park KK, Park JH (2006) Isoliquiritigenin (ISL) inhibits ErbB3 signaling in prostate cancer cells. Biofactors 28:159–168
Hsu YL, Kuo PL, Lin LT, Lin CC (2005) Isoliquiritigenin inhibits cell proliferation and induces apoptosis in human hepatoma cells. Planta Med 71:130–134
Maggiolini M, Statti G, Vivacqua A, Gabriele S, Rago V, Loizzo M, Menichini F, Amdoc S (2002) Estrogenic and antiproliferative activities of isoliquiritigenin in MCF7 breast cancer cells. J Steroid Biochem Mol Biol 82:315–322
Kanga S, Choi J, Choi Y, Bae J, Li J, Kim DS, Kim J, Shin S, Lee Y, Kwun I, Kang Y (2010) Licorice isoliquiritigenin dampens angiogenic activity via inhibition of MAPK-responsive signaling pathways leading to induction of matrix metalloproteinases. J Nutr Biochem 21:55–65
Li D, Wang Z, Chen H, Wang J, Zheng Q, Shang J, Li J (2009) Isoliquiritigenin induces monocytic differentiation of HL-60 cells. Free Radic Biol Med 46:731–736
Zhan C, Yang J (2006) Protective effects of isoliquiritigenin in transient middle cerebral artery occlusion-induced focal cerebral ischemia in rats. Pharmacol Res 53:303–309
Chi JH, Seo GS, Cheon JH, Lee SH (2017) Isoliquiritigenin inhibits TNF-α-induced release of high-mobility group box 1 through activation of HDAC in human intestinal epithelial HT-29 cells. Eur J Pharmacol 796:101–109
Liu S, Zhu L, Zhang J, Yu J, Cheng X, Peng B (2016) Anti-osteoclastogenic activity of isoliquiritigenin via inhibition of NF-κB-dependent autophagic pathway. Biochem Pharmacol 106:82–93
Tsukiyama R, Katsura H, Tokuriki N, Kobayashi M (2002) Antibacterial activity of licochalcone A against spore-forming bacteria. Antimicrob Agents Chemother 46:1226–1230
Chen M, Christensen SB, Blom J, Lemmich E, Nadelmann L, Fich K et al (1993) Licochalcone A, a novel antiparasitic agent with potent activity against human pathogenic protozoan species of Leishmania. Antimicrob Agents Chemother 37:2550–2556
Iwata S, Nishino T, Nagata N, Satomi Y, Nishino H, Shibata S (1995) Antitumorigenic activities of chalcones I. Inhibitory effects of chalcone derivatives on 32P-Incorporation into phospholipids of Hela cells promoted by 12-O- tetradecanoyl-phorbol 13-acetate (TPA). Biol Pharm Bull 18:1710–1713
Chen X, Liu Z, Meng R, Shi C, Guo N (2017) Antioxidative and anticancer properties of Licochalcone A from licorice. J Ethnopharmacol 198:331–337
Rafi MM, Rosen RT, Vassil A, Ho CT, Zhang H, Ghai G, Lambert G, Di Paola RS (2000) Modulation of bcl-2 and cytotoxicity by licochalcone-A, a novel estrogenic flavonoid. Anticancer Res 20:2653–2658
Rafi M, Vastano BC, Zhu N, Ho CT, Ghai G, Rosen RT, Gallo MA, DiPaola RS (2002) Novel polyphenol molecule isolated from licorice root (Glycyrrhiza glabra) induces apoptosis, G2/M cell cycle arrest, and Bcl-2 phosphorylation in tumor cell lines. J Agric Food Chem 50:677–684
Fu Y, Hsieha T, Guo J, Kunicki J, Lee MYWT, Darzynkiewicz Z, Wu JM (2004) Licochalcone-A, a novel flavonoid isolated from licorice root (Glycyrrhiza glabra), causes G2 and late-G1 arrests in androgen-independent PC-3 prostate cancer cells. Biochem Biophys Res Commun 322:263–270
Xiao X, Hao M, Yang X, Ba Q, Li M, Ni S, Wang L, Du X (2011) Licochalcone A inhibits growth of gastric cancer cells by arresting cell cycle progression and inducing apoptosis. Cancer Lett 302:69–75
Won S, Kim S, Kim Y, Lee P, Ryu J, Kim J, Rhee H (2007) Licochalcone A: a lipase inhibitor from the roots of Glycyrrhiza uralensis. Food Res Int 40:1046–1050
Shang F, Ming L, Zhou Z, Yu Y, Sun J, Ding Y, Jin Y (2014) The effect of licochalcone A on cell-aggregates ECM secretion and osteogenic differentiation during bone formation in metaphyseal defects in ovariectomized rats. Biomaterials 35:2789–2797
Oliveira PJ, Carvalho RA, Portincasa P, Bonfrate L, Sardao VA Fatty acid oxidation and cardiovascular risk during menopause: a mitochondrial connection? J Lipids 2012, 2012:365798
Jenkins DJ, Mirrahimi A, Srichaikul K et al (2010) Soy protein reduces serum cholesterol by both intrinsic and food displacement mechanisms. J Nutr 140(12):2302S–2311S
Rigallia JP, Tocchettib GN, Aranab MR, Villanueva SSM, Catania VA, Theile D, Ruiz ML, Weiss J (2016) The phytoestrogen genistein enhances multidrug resistance in breast cancer cell lines by translational regulation of ABC transporters. Cancer Lett 376-1:165–172
Henderson BE, Bernstein L (1991) The international variation in breast cancer rates: an epidemiological assessment. Breast Cancer Res Treat 18(1): S11–S117
Soni M, White LR, Kridawati A, Bandelow S, Hogervorst E (2016) Phytoestrogen consumption and risk for cognitive decline and dementia: with consideration of thyroid status and other possible mediators. J Steroid Biochem Mol Biol 160:67–77
Gopaul R, Knaggs HE, Lephart ED (2012) Biochemical investigation and gene analysis of equol: a plant and soy-derived isoflavonoid with antiaging and antioxidant properties with potential human skin applications. Biofactors 38:44–52
Crain DA, Janssen SJ, Edwards TM, Heindel J, Ho SM, Hunt P, Iguchi T, Juul A, McLachlan JA, Schwartz J, Skakkebaek N, Soto AM, Swan S, Walker C, Woodruff TK, Woodruff TJ, Giudice LC, Guillette LJ Jr (2008) Female reproductive disorders: the roles of endocrine-disrupting compounds and developmental timing. Fertil Steril 90:911–940
This P, Cremoux PD, Leclercq G, Jacquot Y (2011) A critical view of the effects of phytoestrogens on hot flashes and breast cancer risk. Maturitas 70:222–226
Glazier MG, Bowman MA (2001) A review of the evidence for the use of phytoestrogens as a replacement for traditional estrogen replacement therapy. Arch Intern Med 161:1161–1172
Acknowledgments
AA is supported by a research fellowship from the Japan Society for the Promotion of Science.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Fatima, A., Alam, A., Singh, R. (2018). Therapeutic Potential of Phytoestrogens. In: Rani, V., Yadav, U. (eds) Functional Food and Human Health. Springer, Singapore. https://doi.org/10.1007/978-981-13-1123-9_15
Download citation
DOI: https://doi.org/10.1007/978-981-13-1123-9_15
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-1122-2
Online ISBN: 978-981-13-1123-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)